Literature DB >> 2869417

[3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.

D Grigoriadis, P Seeman.   

Abstract

Dopamine recognized and competed for a single population of [3H]-domperidone-binding sites in rat striatum and olfactory tubercle when tested in the presence of sodium ions and guanine nucleotide [Gpp(NH)p]. In the absence of Na+ and Gpp(NH)p, however, dopamine recognized two components of [3H]-domperidone binding. Thus, [3H]-domperidone labelled only a single population of dopamine receptors (type D2) which fully converted from high to low affinity for dopamine. These results agree with those found previously using [3H]-spiperone and [3H]-YM-09151-2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869417     DOI: 10.1007/bf00633192

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

2.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

Authors:  J E Leysen; W Gommeren; P M Laduron
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

3.  Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.

Authors:  S R George; M Watanabe; P Seeman
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

4.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

Authors:  M W Hamblin; S E Leff; I Creese
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates.

Authors:  S Lazareno
Journal:  J Recept Res       Date:  1983

7.  3H-Domperidone: a selective ligand for dopamine receptors.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

8.  Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

Authors:  H B Niznik; D E Grigoriadis; I Pri-Bar; O Buchman; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

9.  3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.

Authors:  P Sokoloff; K Redouane; M Brann; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

10.  3H-Dopamine binding sites differ in rat striatum and pituitary.

Authors:  P Sokoloff; M P Martres; M Delandre; K Redouane; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

View more
  8 in total

1.  Cloning of the cDNA and gene for a human D2 dopamine receptor.

Authors:  D K Grandy; M A Marchionni; H Makam; R E Stofko; M Alfano; L Frothingham; J B Fischer; K J Burke-Howie; J R Bunzow; A C Server
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 2.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

3.  Heterogeneity of D2 dopamine receptors in different brain regions.

Authors:  M N Leonard; C A Macey; P G Strange
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

4.  Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.

Authors:  S Urwyler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 5.  Reward, addiction, withdrawal to nicotine.

Authors:  Mariella De Biasi; John A Dani
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

6.  Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Authors:  T A Reader; E Molina-Holgado; K M Dewar
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

7.  Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.

Authors:  C Semeraro; R Ferrini; L Allievi; F Pocchiari; S Nicosia; C Casagrande
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

8.  Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.

Authors:  S Urwyler; D Coward
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.